Evaluation of the Relationship of MPV, RDW and PVI Parameters with Disease Severity in Covid-19 Patients
Yazarlar (2)
Doç. Dr. Dilek Atik Karamanoğlu Mehmetbey Üniversitesi, Türkiye
Dr. Öğr. Üyesi Hasan Burak KAYA Bozok Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | Acta Clinica Croatica (Q3) | ||
| Dergi ISSN | 0353-9466 Dergi Bilgileri (2021) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 01-2021 |
| Kabul Tarihi | – | Yayınlanma Tarihi | 01-01-2021 |
| Cilt / Sayı / Sayfa | 60 / 1 / 103–114 | DOI | 10.20471/acc.2021.60.01.15 |
| Makale Linki | http://dx.doi.org/10.20471/acc.2021.60.01.15 | ||
| UAK Araştırma Alanları |
Acil Tıp
|
||
| Özet |
| Coronavirus was first detected in three severe pneumonia cases in Wuhan, China, in December 2019. Studies on red cell distribution width (RDW-CV) and mean platelet volume (MPV) laboratory parameters, which can be examined in complete blood count in COVID-19 patients, are still very limited. However, to the best of our knowledge, there are no studies examining the relationship between platelet volume index (PVI) and disease severity in COVID-19 patients, which was evaluated in this study. The aim of this study was to evaluate the relationship of disease severity in COVID-19 patients with their MPV, RDW, and PVI parameters. The study included 92 COVID-19 patients as a study group and 84 healthy individuals as control group. All laboratory data and radiological images were scanned retrospectively from patient files and hospital information system. Evaluation of the RDW-CV and MPV blood parameters, and PVI measured in COVID-19 patients yielded statistically significant differences according to the disease severity. We suggest that RDW-CV and PVI, evaluated within the scope of the study, may be the parameters that should be considered in the early diagnosis of the disease, from the initial stages of COVID-19. In addition, we think that the RDW-CV and MPV laboratory parameters, as well as PVI, which all are simple, inexpensive and widely used hematologic tests, can be used as important biomarkers in determining COVID-19 severity and mortality. |
| Anahtar Kelimeler |
| COVID-19 | Disease severity | Mean platelet volume | Platelet volume index | Red cell distribution width |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 21 |
| Scopus | 23 |
| Google Scholar | 36 |